EMAIL US AT info@bcan.org
Contact Us 888-901-2226
Donate Now

Photocure Announces FDA Approval of New Drug Application for Blue Light Cystoscopy with Cysview®

February 16, 2018– Today Photocure ASA announced the FDA approval of new indications for Blue Light Cystoscopy (BLC™) with Cysview®.  This supplemental new drug application (sNDA) will include Flexible Cystoscopes, which are used in the ongoing surveillance of bladder cancer patients bladder cancer. It is the only combination of drug and device approved for the detection of this disease.

“This expanded approval in both rigid and flexible blue light cystoscopy (BLC) means that Cysview can now be used during transurethral resection of bladder cancer surgery for diagnosis and staging, as well as with follow-up surveillance of non-muscle invasive bladder cancer (NMIBC).”
– Gary Steinberg, MD, The University of Chicago

Walk with BCAN, Talk with BCAN

Please join us for two exciting virtual events
in October 2020

Fall Virtual Walk to End Bladder Cancer
October 3, 2020 at 11:00 am ET

Virtual Summit for Patients and Families
October 10, 2020 at 1:00 pm ET